Nitric oxide and its derivatives in the cancer battlefield.

Elevated levels of reactive nitrogen species, alteration in redox balance and deregulated redox signaling are common hallmarks of cancer progression and chemoresistance. However, depending on the cellular context, distinct reactive nitrogen species are also hypothesized to mediate cytotoxic activity and are thus used in anticancer therapies. We present here the dual face of nitric oxide and its derivatives in cancer biology. Main derivatives of nitric oxide, such as nitrogen dioxide and peroxynitrite cause cell death by inducing protein and lipid peroxidation and/or DNA damage. Moreover, they control the activity of important protein players within the pro- and anti-apoptotic signaling pathways. Thus, the control of intracellular reactive nitrogen species may become a sophisticated tool in anticancer strategies.

[1]  A. Stern,et al.  Nitric oxide: Protein tyrosine phosphorylation and protein S-nitrosylation in cancer , 2015, Biomedical journal.

[2]  Yu-Chao Wang,et al.  Heat-activated sustaining nitric oxide release from zwitterionic diazeniumdiolate loaded in thermo-sensitive liposomes. , 2010, Nitric oxide : biology and chemistry.

[3]  N. Hogg,et al.  Cancer cell metabolism and the modulating effects of nitric oxide. , 2015, Free radical biology & medicine.

[4]  B. Brüne,et al.  Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. , 1997, Kidney international.

[5]  R. Jain,et al.  The role of nitric oxide in tumour progression , 2006, Nature Reviews Cancer.

[6]  R. Stephens,et al.  Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. , 2010, The Journal of clinical investigation.

[7]  M. Kirsch,et al.  Formation of Peroxynitrite from Reaction of Nitroxyl Anion with Molecular Oxygen* , 2002, Journal of Biological Chemistry.

[8]  M. Gladwin,et al.  Nitrate and nitrite in biology, nutrition and therapeutics. , 2009, Nature chemical biology.

[9]  M. N. Hughes,et al.  Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite. , 1999, Biochimica et biophysica acta.

[10]  William L. Jorgensen,et al.  The Organic Chemist's Book of Orbitals , 1973 .

[11]  Giosuè Lo Bosco,et al.  2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells. , 2018, Cancer genomics & proteomics.

[12]  L. Oberley,et al.  Superoxide dismutase activity of Ehrlich ascites tumor cells. , 1977, Journal of the National Cancer Institute.

[13]  C. Cross,et al.  Formation of Reactive Nitrogen Species during Peroxidase-catalyzed Oxidation of Nitrite , 1997, The Journal of Biological Chemistry.

[14]  E. Mazzon,et al.  Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells , 2018, Molecules.

[15]  M. Gladwin,et al.  Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Żmijewski,et al.  Neuronal Nitric Oxide Synthase Induction in the Antitumorigenic and Neurotoxic Effects of 2-Methoxyestradiol , 2014, Molecules.

[17]  D. Wink,et al.  Biological nitric oxide signalling: chemistry and terminology , 2013, British journal of pharmacology.

[18]  Bonnie A. Merchant,et al.  Nitrite Reductase and Nitric-oxide Synthase Activity of the Mitochondrial Molybdopterin Enzymes mARC1 and mARC2* , 2014, The Journal of Biological Chemistry.

[19]  W. Pryor,et al.  The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. , 1995, The American journal of physiology.

[20]  A. Denicola,et al.  Nitrogen dioxide solubility and permeation in lipid membranes. , 2011, Archives of biochemistry and biophysics.

[21]  T. Galeotti,et al.  Superoxide radicals and hydrogen peroxide formation in mitochondria from normal and neoplastic tissues. , 1975, Biochimica et biophysica acta.

[22]  B. Bonavida,et al.  Mechanisms of nitric oxide-mediated inhibition of EMT in cancer , 2010, Cell cycle.

[23]  J. Otte,et al.  Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells. , 2010, Neoplasia.

[24]  J. K. Hurst,et al.  CO2-Catalyzed One-Electron Oxidations by Peroxynitrite: Properties of the Reactive Intermediate , 1998 .

[25]  B. Freeman,et al.  Olives and Olive Oil Are Sources of Electrophilic Fatty Acid Nitroalkenes , 2014, PloS one.

[26]  C. Giulivi,et al.  Biochemistry of Mitochondrial Nitric-oxide Synthase* , 2002, The Journal of Biological Chemistry.

[27]  J. Stephenson,et al.  Vibrational predissociation of the nitric oxide dimer: Total energy distribution in the fragments , 1986 .

[28]  K. Kashfi,et al.  The dual role of iNOS in cancer☆ , 2015, Redox biology.

[29]  B. Freeman,et al.  Formation and signaling actions of electrophilic lipids. , 2011, Chemical reviews.

[30]  L. Ignarro,et al.  In Vivo Aspects of Nitric Oxide (NO) Chemistry: Does Peroxynitrite (-OONO) Play a Major Role in Cytotoxicity? , 1997 .

[31]  R. Mendel,et al.  Molybdenum cofactor biosynthesis and molybdenum enzymes. , 2006, Annual review of plant biology.

[32]  A. Morelli,et al.  Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. , 2003, Gastroenterology.

[33]  M. Gordon,et al.  Structures, Bonding, and Energetics of N2O2 Isomers , 1994 .

[34]  W. Pryor,et al.  Rates and mechanisms of reactions of nitrogen dioxide with alkenes in solution , 1987 .

[35]  A. Ahluwalia,et al.  Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite , 2008, Hypertension.

[36]  C. Ratanatawanate,et al.  S-nitrosocysteine-decorated PbS QDs/TiO2 nanotubes for enhanced production of singlet oxygen. , 2011, Journal of the American Chemical Society.

[37]  A. Girotti,et al.  Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy. , 2016, Current medicinal chemistry.

[38]  D. Matei,et al.  Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial. , 2009, Gynecologic oncology.

[39]  J. Zweier,et al.  Characterization of the Magnitude and Mechanism of Aldehyde Oxidase-mediated Nitric Oxide Production from Nitrite* , 2009, The Journal of Biological Chemistry.

[40]  D. Zhu,et al.  Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. , 2009, Nitric oxide : biology and chemistry.

[41]  C. Yiannoutsos,et al.  A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer , 2005, Clinical Cancer Research.

[42]  M. Kirsch,et al.  The Pathobiochemistry of Nitrogen Dioxide , 2002, Biological chemistry.

[43]  M. Haigis,et al.  Mitochondria and Cancer , 2016, Cell.

[44]  Tianxin Yang,et al.  Protection of nitro-fatty acid against kidney diseases. , 2016, American journal of physiology. Renal physiology.

[45]  D. Busija,et al.  Mitochondrial nitric oxide synthase: current concepts and controversies. , 2009, Frontiers in bioscience.

[46]  M. Harrison,et al.  A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC) , 2011, Investigational New Drugs.

[47]  P. Richardson,et al.  Novel Therapy with 2-Methoxyestradiol for the Treatment of Relapsed and Plateau Phase Multiple Myeloma , 2007, Clinical Cancer Research.

[48]  J. McCubrey,et al.  The antitumor properties of a nontoxic, nitric oxide–modified version of saquinavir are independent of Akt , 2009, Molecular Cancer Therapeutics.

[49]  J. Patel,et al.  Influence of epithelial lining fluid lipids on NO(2)-induced membrane oxidation and nitration. , 2003, Free radical biology & medicine.

[50]  S. Ambs,et al.  Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer. , 2011, Trends in pharmacological sciences.

[51]  Wangling,et al.  Sulfite Oxidase Catalyzes Single-Electron Transfer at Molybdenum Domain to Reduce Nitrite to Nitric Oxide. , 2015, Antioxidants & redox signaling.

[52]  A. Gadbail,et al.  Nitric oxide and cancer: a review , 2013, World Journal of Surgical Oncology.

[53]  E. Weitzberg,et al.  The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. , 2008, Nitric oxide : biology and chemistry.

[54]  B. Mayer,et al.  Protein Tyrosine Nitration in Cytokine-activated Murine Macrophages , 2001, The Journal of Biological Chemistry.

[55]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[56]  Jianhua Zhang,et al.  Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling , 2011, The Biochemical journal.

[57]  V. Poornima,et al.  Nitric oxide and oral cancer: a review. , 2012, Oral oncology.

[58]  C. Lindermayr,et al.  Nitric oxide-based protein modification: formation and site-specificity of protein S-nitrosylation , 2013, Front. Plant Sci..

[59]  A. Friebe,et al.  This Review Is Part of a Thematic Series on Cyclic Gmp–generating Enzymes and Cyclic Gmp–dependent Signaling, Which Includes the following Articles: Regulation of Nitric Oxide–sensitive Guanylyl Cyclase Cyclic Gmp Phosphodiesterases and Regulation of Smooth Muscle Function Structure, Regulation, and , 2022 .

[60]  L. Liaudet,et al.  Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.

[61]  BasudharDebashree,et al.  Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression. , 2017 .

[62]  Z. Iqbal,et al.  Role of nitrogen dioxide in the biosynthesis of nitraosamines in mice. , 1980, Science.

[63]  D. Wink,et al.  I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[64]  E. Werner,et al.  Metabolic Fate of Peroxynitrite in Aqueous Solution , 1997, The Journal of Biological Chemistry.

[65]  S. Steinberg,et al.  Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors , 2006, Cancer biology & therapy.

[66]  Y. Janssen-Heininger,et al.  In situ analysis of protein S-glutathionylation in lung tissue using glutaredoxin-1-catalyzed cysteine derivatization. , 2009, The American journal of pathology.

[67]  Jifeng Zhang,et al.  Nitrated Fatty Acids: Endogenous Anti-inflammatory Signaling Mediators* , 2006, Journal of Biological Chemistry.

[68]  D. Townsend,et al.  S-Glutathionylation of Protein Disulfide Isomerase Regulates Estrogen Receptor α Stability and Function , 2012, International journal of cell biology.

[69]  J. Fukuto,et al.  Chemistry of nitric oxide: biologically relevant aspects. , 1995, Advances in pharmacology.

[70]  Robert M. Rapoport,et al.  Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation , 1983, Nature.

[71]  R. Eisenthal,et al.  Reduction of organic nitrites to nitric oxide catalyzed by xanthine oxidase: possible role in metabolism of nitrovasodilators. , 2000, Biochemical and biophysical research communications.

[72]  E. Cavalli,et al.  The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K. , 2015, Leukemia research.

[73]  D. Deamer,et al.  Superoxide dismutase activity in WI-38 cell cultures: effects of age, trypsinization and SV-40 transformation. , 1974, Physiological chemistry and physics.

[74]  Jun Yang,et al.  Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase , 2014, Proceedings of the National Academy of Sciences.

[75]  B. Zhivotovsky,et al.  Mitophagy: Link to cancer development and therapy. , 2017, Biochemical and biophysical research communications.

[76]  P. Puigserver,et al.  PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors. , 2016, Trends in cancer.

[77]  Guy C. Brown Nitric oxide and mitochondria. , 2007, Frontiers in bioscience : a journal and virtual library.

[78]  Jeannette Bigler,et al.  Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics , 2006, Nature Reviews Cancer.

[79]  E. Kool,et al.  Hydrophobic, Non-Hydrogen-Bonding Bases and Base Pairs in DNA. , 1995, Journal of the American Chemical Society.

[80]  A. Seabra,et al.  Nitric oxide donor superparamagnetic iron oxide nanoparticles. , 2013, Materials science & engineering. C, Materials for biological applications.

[81]  S. Ferng,et al.  DNA strand breaks caused by exposure to ozone and nitrogen dioxide. , 1999, Environmental research.

[82]  S. Glynn,et al.  The yin and yang of nitric oxide in cancer progression. , 2013, Carcinogenesis.

[83]  E. Clementi,et al.  Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide , 2003, Science.

[84]  B. Freeman,et al.  Nitro-fatty acid pharmacokinetics in the adipose tissue compartment[S] , 2017, Journal of Lipid Research.

[85]  A. Vanin,et al.  Nitric oxide synthase reduces nitrite to NO under anoxia , 2006, Cellular and Molecular Life Sciences.

[86]  J. Hetzler,et al.  Product energy correlations in the dissociation of overtone excited nitric oxide dimer , 1991 .

[87]  G. Merényi,et al.  Tyrosine Nitration by Simultaneous Generation of ⋅NO and O⨪2 under Physiological Conditions , 2000, The Journal of Biological Chemistry.

[88]  A. Schechter,et al.  Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits , 2011, European journal of nutrition.

[89]  B. Mayer,et al.  A New Pathway of Nitric Oxide/Cyclic GMP Signaling InvolvingS-Nitrosoglutathione* , 1998, The Journal of Biological Chemistry.

[90]  A. Martínez-Ruíz,et al.  S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells. , 2011, Gastroenterology.

[91]  F. Kassie,et al.  Nitric oxide-donating aspirin (NO-Aspirin) suppresses lung tumorigenesis in vitro and in vivo and these effects are associated with modulation of the EGFR signaling pathway , 2018, Carcinogenesis.

[92]  Li Gao,et al.  Nitric oxide-donating aspirin induces G2/M phase cell cycle arrest in human cancer cells by regulating phase transition proteins. , 2012, International journal of oncology.

[93]  G. Squadrito,et al.  On the hydrophobicity of nitrogen dioxide: could there be a "lens" effect for NO(2) reaction kinetics? , 2009, Nitric oxide : biology and chemistry.

[94]  D. Atochin,et al.  Nitric oxide and mitochondria in metabolic syndrome , 2015, Front. Physiol..

[95]  J. K. Hurst,et al.  Hydroxyl Radical Formation during Peroxynitrous Acid Decomposition , 1999 .

[96]  S Moncada,et al.  Nitric oxide synthases in mammals. , 1994, The Biochemical journal.

[97]  Chandan K Sen,et al.  Mitochondrial nitric oxide synthase. , 2005, Trends in pharmacological sciences.

[98]  C. Harris,et al.  Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[99]  D. Wink,et al.  Modulation of Superoxide-dependent Oxidation and Hydroxylation Reactions by Nitric Oxide (*) , 1996, The Journal of Biological Chemistry.

[100]  J. Schrader,et al.  Control of coronary vascular tone by nitric oxide. , 1990, Circulation research.

[101]  Saranya Rajendran,et al.  Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling. , 2019, Comprehensive Physiology.

[102]  L. Ignarro,et al.  Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[103]  Lucas B. Sullivan,et al.  Mitochondrial reactive oxygen species and cancer , 2014, Cancer & Metabolism.

[104]  H. Ohshima,et al.  Nitrative DNA damage in inflammation and its possible role in carcinogenesis. , 2006, Nitric oxide : biology and chemistry.

[105]  James K. G. Watson,et al.  THE NO DIMER : 15N ISOTOPIC INFRARED SPECTRA, LINE-WIDTHS, AND FORCE FIELD , 1995 .

[106]  J. Meyerhardt,et al.  A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors , 2011, Cancer Chemotherapy and Pharmacology.

[107]  G. Wilding,et al.  A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate , 2012, Investigational New Drugs.

[108]  D. Townsend,et al.  Causes and Consequences of Cysteine S-Glutathionylation* , 2013, The Journal of Biological Chemistry.

[109]  K. Appel,et al.  Niltrogen dioxide induces DNA single-strand breaks in cultured Chinese hamster cells , 1990 .

[110]  N. Bryan,et al.  Cellular targets and mechanisms of nitros(yl)ation: An insight into their nature and kinetics in vivo , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[111]  S. Shiva Mitochondria as metabolizers and targets of nitrite. , 2010, Nitric oxide : biology and chemistry.

[112]  S. Rodríguez-Enríquez,et al.  Selective degradation of mitochondria by mitophagy. , 2007, Archives of biochemistry and biophysics.

[113]  G. Sledge,et al.  Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer , 2006, Investigational New Drugs.

[114]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.

[115]  C. Sen,et al.  Mitochondrial nitric oxide synthase. , 2007, Frontiers in bioscience : a journal and virtual library.

[116]  S. Ambs,et al.  S-Nitrosation Mediates Multiple Pathways That Lead to Tumor Progression in Estrogen Receptor-Negative Breast Cancer. , 2012, Forum on immunopathological diseases and therapeutics.

[117]  D. Naughton,et al.  Human xanthine oxidase converts nitrite ions into nitric oxide (NO). , 1997, Biochemical Society transactions.

[118]  M. Wozniak,et al.  Nitro-oxidative Stress Is Involved in Anticancer Activity of 17β-Estradiol Derivative in Neuroblastoma Cells. , 2016, Anticancer research.

[119]  N. Davidson,et al.  Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth , 2017, The Journal of Biological Chemistry.

[120]  Francesca Benedini,et al.  Positional Isomerism Markedly Affects the Growth Inhibition of Colon Cancer Cells by Nitric Oxide-Donating Aspirin in Vitro and in Vivo , 2005, Journal of Pharmacology and Experimental Therapeutics.

[121]  M. Marinus,et al.  Nitric Oxide-Induced Homologous Recombination in Escherichia coli Is Promoted by DNA Glycosylases , 2002, Journal of bacteriology.

[122]  A. Girotti Upregulation of nitric oxide in tumor cells as a negative adaptation to photodynamic therapy , 2018, Lasers in surgery and medicine.

[123]  G. Wilding,et al.  Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies , 2009, Clinical Cancer Research.

[124]  A. Girotti,et al.  Nitric Oxide Antagonism to Anti-Glioblastoma Photodynamic Therapy: Mitigation by Inhibitors of Nitric Oxide Generation , 2019, Cancers.

[125]  J. Hodgson,et al.  Dietary Nitrate, Nitric Oxide, and Cardiovascular Health , 2016, Critical reviews in food science and nutrition.

[126]  M. Ciriolo,et al.  Nuclear Recruitment of Neuronal Nitric-oxide Synthase by α-Syntrophin Is Crucial for the Induction of Mitochondrial Biogenesis* , 2013, The Journal of Biological Chemistry.

[127]  C. Giulivi,et al.  Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. , 2010, Free radical biology & medicine.

[128]  M. Donia,et al.  In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells , 2011, Cell cycle.

[129]  Mark T. Gladwin,et al.  The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics , 2008, Nature Reviews Drug Discovery.

[130]  Liying Wang,et al.  S-Nitrosylation of Bcl-2 Inhibits Its Ubiquitin-Proteasomal Degradation , 2006, Journal of Biological Chemistry.

[131]  A. Volterra,et al.  Differential Modulation of the Uptake Currents by Redox Interconversion of Cysteine Residues in the Human Neuronal Glutamate Transporter EAAC1 , 1997, The European journal of neuroscience.

[132]  G. Reiser,et al.  The ionization energy of nitric oxide , 1988 .

[133]  B. Mayer,et al.  Lack of Tyrosine Nitration by Peroxynitrite Generated at Physiological pH* , 1998, The Journal of Biological Chemistry.

[134]  A. Denicola,et al.  Diffusion and Transport of Reactive Species Across Cell Membranes. , 2019, Advances in experimental medicine and biology.

[135]  M. Wozniak,et al.  Effect of 2-Methoxyestradiol on Dephosphorylation of Neuronal Nitric Oxide Synthase in Osteosarcoma 143B Cells. An in vitro study , 2015 .

[136]  C. Piantadosi,et al.  Redox regulation of mitochondrial biogenesis. , 2012, Free radical biology & medicine.

[137]  J. M. Marchetti,et al.  Nanocarriers for Nitric Oxide Delivery , 2011, Journal of drug delivery.

[138]  B. Freeman,et al.  Generation and esterification of electrophilic fatty acid nitroalkenes in triacylglycerides. , 2015, Free radical biology & medicine.

[139]  S. Padmaja,et al.  The reaction of no with superoxide. , 1993, Free radical research communications.

[140]  D. Wink,et al.  Nitric Oxide I . Physiological chemistry of nitric oxide and its metabolites : implications in inflammation , 1999 .

[141]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 (HIF-1) Pathway , 2007, Science's STKE.

[142]  D. Wink,et al.  Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. , 1998, Free radical biology & medicine.

[143]  J. Murrell,et al.  Structure and stability of the nitric oxide dimer , 1971 .

[144]  R. Cress,et al.  Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.

[145]  Jenny C. Chang,et al.  Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast Cancer , 2018, Clinical Cancer Research.

[146]  V. Rohde,et al.  Expression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumors , 2014, Neurosurgical Review.

[147]  M. Calderón,et al.  Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives. , 2015, Current topics in medicinal chemistry.

[148]  A. L. East The 16 valence electronic states of nitric oxide dimer (NO)2 , 1998 .

[149]  L. Hofseth,et al.  An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. , 2007, Cancer research.

[150]  R. Kaufman,et al.  Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? , 2007, Antioxidants & redox signaling.

[151]  L. Oberley Mechanism of the tumor suppressive effect of MnSOD overexpression. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[152]  S. Goldstein,et al.  Formation of Peroxynitrate from the Reaction of Peroxynitrite with CO2: Evidence for Carbonate Radical Production , 1998 .

[153]  J. Watson,et al.  The intermolecular vibrations of the NO dimer , 1998 .

[154]  P. Mouthuy,et al.  European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) , 2017, Redox biology.

[155]  J. Drapier,et al.  Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. , 1986, The Journal of clinical investigation.

[156]  F. Cappello,et al.  DNA strand breaks induced by nuclear hijacking of neuronal NOS as an anti-cancer effect of 2-methoxyestradiol , 2015, Oncotarget.

[157]  C. Leifert,et al.  Dietary nitrate in man: friend or foe? , 1999, British Journal of Nutrition.

[158]  F. W. Flitney,et al.  NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. , 1995, Trends in pharmacological sciences.

[159]  Fang Li,et al.  Regulation of HIF-1α Stability through S-nitrosylation , 2007 .

[160]  Jae Ho Shin,et al.  Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth. , 2010, Molecular pharmaceutics.

[161]  B. Halliwell,et al.  Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. , 1996, The Biochemical journal.

[162]  H. Bergh,et al.  The heat of formation of the nitric oxide dimer and its UV spectrum , 1978 .

[163]  N. Bryan,et al.  Food sources of nitrates and nitrites: the physiologic context for potential health benefits. , 2009, The American journal of clinical nutrition.

[164]  E. Mazzon,et al.  Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo , 2019, Investigational New Drugs.

[165]  B. Banecki,et al.  Pivotal participation of nitrogen dioxide in L-arginine induced acute necrotizing pancreatitis: protective role of superoxide scavenger 4-OH-TEMPO. , 2005, Biochemical and biophysical research communications.

[166]  B. Oronsky,et al.  The Implications of Hyponitroxia in Cancer , 2014, Translational oncology.

[167]  S. Stoltze,et al.  Nitrate and nitrite in vegetables on the Danish market: content and intake. , 1999, Food additives and contaminants.

[168]  Lingqun Zhu,et al.  iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer , 2017, Oncotarget.

[169]  A. Kim Modulation of MnSOD in Cancer:Epidemiological and Experimental Evidence , 2010, Toxicological research.

[170]  Wei Chen,et al.  Myricitrin protects against peroxynitrite-mediated DNA damage and cytotoxicity in astrocytes. , 2013, Food chemistry.

[171]  F. Traganos,et al.  Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention. , 2001, Cancer research.

[172]  J. Wierzbicka,et al.  Role of Oxidative and Nitro-Oxidative Damage in Silver Nanoparticles Cytotoxic Effect against Human Pancreatic Ductal Adenocarcinoma Cells , 2018, Oxidative medicine and cellular longevity.

[173]  L. Folkes,et al.  DNA damage induced by nitric oxide during ionizing radiation is enhanced at replication. , 2013, Nitric oxide : biology and chemistry.

[174]  K. Houk,et al.  Mechanisms of peroxynitrite-mediated nitration of tyrosine. , 2009, Chemical research in toxicology.

[175]  S. Berchmans,et al.  Nitric oxide releasing photoresponsive nanohybrids as excellent therapeutic agent for cervical cancer cell lines. , 2013, ACS Applied Materials and Interfaces.

[176]  H. E. Marshall,et al.  Protein S-nitrosylation: purview and parameters , 2005, Nature Reviews Molecular Cell Biology.

[177]  T. Mak,et al.  Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.

[178]  G. Shapiro,et al.  ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors , 2016, Cancer Chemotherapy and Pharmacology.

[179]  V. Bowry,et al.  The Complex Chemistry of Peroxynitrite Decomposition: New Insights1 , 1998 .

[180]  K. Schmidt,et al.  Protein tyrosine nitration in mouse peritoneal macrophages activated in vitro and in vivo: evidence against an essential role of peroxynitrite , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[181]  A. Kozlov,et al.  Nitrite reductase activity is a novel function of mammalian mitochondria , 1999, FEBS letters.

[182]  Lech Chmurzynski,et al.  A Novel Biosensor for Evaluation of Apoptotic or Necrotic Effects of Nitrogen Dioxide during Acute Pancreatitis in Rat , 2009, Sensors.

[183]  S. Qian,et al.  Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer. , 2019, Nitric oxide : biology and chemistry.

[184]  E. Weitzberg,et al.  A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. , 2008, Nature chemical biology.

[185]  S. Rybárová,et al.  Expression of peptidergic and nitrergic structures in dorsal root ganglia of the rabbit. , 2000, European journal of histochemistry : EJH.

[186]  Min Guan,et al.  Anti-HIV drugs for cancer therapeutics: back to the future? , 2009, The Lancet. Oncology.

[187]  G. Chaudhuri,et al.  Nitric-oxide-induced Bax integration into the mitochondrial membrane commits MDA-MB-468 cells to apoptosis: essential role of Akt. , 2003, Cancer research.

[188]  K. Kashfi,et al.  Nitric-oxide-donating NSAIDs as agents for cancer prevention. , 2004, Trends in molecular medicine.

[189]  R. Radi Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine , 2018, Proceedings of the National Academy of Sciences.

[190]  S. Ambs,et al.  Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression , 2014, Proceedings of the National Academy of Sciences.

[191]  S. Cai,et al.  Multi-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinoma. , 2012, Biomaterials.

[192]  A. Girotti Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide , 2016, Cancers.

[193]  R. Mendel,et al.  Molybdenum cofactors, enzymes and pathways , 2009, Nature.

[194]  Y. E. Chen,et al.  Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts. , 2013, Cardiovascular research.

[195]  R. Hille,et al.  Mechanism of nitrite-dependent NO synthesis by human sulfite oxidase. , 2019, The Biochemical journal.

[196]  E. Ford,et al.  Kinetics of the reactions of nitrogen dioxide with glutathione, cysteine, and uric acid at physiological pH. , 2002, Free radical biology & medicine.

[197]  Shazia Khan,et al.  Interactions of Nitric Oxide and Redox-related species with biological targets , 1995 .

[198]  M. Dikshit,et al.  Cdk2 nitrosylation and loss of mitochondrial potential mediate NO-dependent biphasic effect on HL-60 cell cycle. , 2010, Free radical biology & medicine.

[199]  M. P. Cole,et al.  Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion. , 2010, Cardiovascular research.